← Back to Search

LFR-260 portable phoropter for Anisometropia

N/A
Waitlist Available
Research Sponsored by Evolution Optiks Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights

Study Summary

This trial will study whether LFR-260 is as effective as a traditional phoropter in a routine eye examination.

Eligible Conditions
  • Anisometropia
  • Visual Acuity
  • Astigmatism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of LFR260 on Visual Acuity test
Precision of LFR260 in repeated testing
Secondary outcome measures
Patient Satisfaction Survey
Provider Satisfaction Survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LFR-260Experimental Treatment1 Intervention
The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams.
Group II: Traditional phoropterActive Control1 Intervention
The traditional phoropter is intended to be used for distance vision testing in any environment. The traditional phoropter is an application-controlled instrument providing the same subjective refraction capabilities for distance vision testing as the standard of care eye examination including sphere, cylinder, and axis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LFR-260 portable phoropter
2022
N/A
~120

Find a Location

Who is running the clinical trial?

Evolution Optiks LimitedLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~40 spots leftby May 2025